What is it about?
Citicoline is hypothesized to improve the cholinergic system of the brain. Two retrospective cohorts involving 563 patients were analyzed in this review. Limited evidence suggests that citicoline as adjunct may improve cognitive function.
Photo by Steven HWG on Unsplash
Why is it important?
We believe this publication will be of great importance to the scientific community as this study determined the effects of citicoline as an adjunct treatment to acetylcholinesterase inhibitors for patients with Alzheimer disease through systematic review of relevant studies.
Read the Original
This page is a summary of: Effects of Citicoline as an Adjunct Treatment for Alzheimer’s Disease: A Systematic Review, Journal of Alzheimer s Disease, June 2020, IOS Press, DOI: 10.3233/jad-200378.
You can read the full text:
The following have contributed to this page